platinum has been researched along with melphalan in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gottikh, BP; Grokhovskiĭ, SL; Zhuze, AL | 1 |
| Edgren, M; Fichtinger-Schepman, AM; Hansson, J; Ringborg, U | 1 |
| Culo, F; Spellman, JM; Yuhas, JM | 1 |
| Dupuis, NP; Emi, Y; Goff, DA; Robinson, MF; Teicher, BA | 1 |
| Adjei, AA; Bruzek, LM; Davis, JN; Erlichman, C; Kaufmann, SH | 1 |
5 other study(ies) available for platinum and melphalan
| Article | Year |
|---|---|
[Ligands possessing affinity to specific DNA base pair sequences. IX. Synthesis of netropsin and distamycin A analogs having sarcolysin residues or a platinum(II) atom].
Topics: Base Composition; Cisplatin; Distamycins; DNA; Ligands; Melphalan; Netropsin; Platinum | 1992 |
Comparative study of two human melanoma cell lines with different sensitivities to mustine and cisplatin.
Topics: Cell Line; Cell Survival; Cisplatin; DNA, Neoplasm; Glutathione; Humans; Mechlorethamine; Melanoma; Melphalan; Platinum; Tumor Cells, Cultured | 1991 |
The role of WR-2721 in radiotherapy and/or chemotherapy.
Topics: Alkylating Agents; Amifostine; Animals; Breast Neoplasms; Cyclophosphamide; Humans; In Vitro Techniques; Mechlorethamine; Melphalan; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Organothiophosphorus Compounds; Platinum; Rabbits; Radiation-Protective Agents; Rats; Time Factors | 1980 |
Antiangiogenic treatment (TNP-470/minocycline) increases tissue levels of anticancer drugs in mice bearing Lewis lung carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Carmustine; Cell Hypoxia; Cell Survival; Cisplatin; Cyclohexanes; Cyclophosphamide; DNA, Neoplasm; Drug Combinations; Male; Melphalan; Mice; Mice, Inbred C57BL; Minocycline; O-(Chloroacetylcarbamoyl)fumagillol; Platinum; Sesquiterpenes; Tumor Cells, Cultured | 1995 |
Synergy of the protein farnesyltransferase inhibitor SCH66336 and cisplatin in human cancer cell lines.
Topics: Alkyl and Aryl Transferases; Antineoplastic Agents; Apoptosis; Cell Cycle; Cisplatin; DNA Adducts; Drug Combinations; Drug Synergism; Fluorouracil; Humans; Melphalan; Piperidines; Platinum; Pyridines; Tumor Cells, Cultured | 2001 |